Skip to main content

Table 1 Prevalence and severity of diabetic retinopathy and macular edema by gender

From: Prevalence of diabetic retinopathy in Tehran province: a population-based study

 

Total persons with diabetes

(N = 634)

Men with diabetes

(N = 287)

Women with diabetes

(N = 347)

P¶

 

n

Crude†

Standardized*

n

Crude†

Standardized*

n

Crude†

Standardized*

 

Any retinopathy

240

37.9

(34.1-41.6)

37.0

(33.2-40.8)

124

43.2

(37.4-49)

43.9

(38.1-49.6)

116

33.4

(28.4-38.4)

33.1

(28.1-38.0)

0.005

CSME§

38

6.0

(4.1-7.8)

5.8

(4.0-7.7)

20

6.9

(3.9-9.8)

6.9

(4.0-9.8)

18

5.2

(2.8-7.5)

5.3

(2.9-7.6)

<0.001

VTR§

95

15

(12.2-17.8)

14.0

(11.3-16.7)

58

20.2

(15.5-24.9)

21.9

(17.1-26.7)

37

10.7

(7.4-13.9)

9.5

(6.4-12.6)

<0.001

Retinopathy Grades

          

NPDR

175

27.6

(24.1-31.1)

27.3

(23.7-30.8)

85

29.6

(24.3-34.9)

29.3

(24.0-34.6)

90

25.9

(21.3-30.6)

26.2

(21.6-30.9)

<0.001

Mild NPDR

114

17.8

(14.9-20.8)

17.9

(14.9-20.9)

53

18.2

(13.8-22.7)

17.7

(13.3-22.1)

61

17.5

(13.5-21.5)

17.9

(13.9-22.0)

<0.001

Moderate NPDR

42

6.6

(4.6-8.5)

6.6

(4.7-8.6)

20

6.9

(3.9-9.8)

6.4

(3.6-9.2)

22

6.3

(3.8-8.9)

6.7

(4.1-9.4)

0.024

Severe NPDR

19

3

(1.7-4.3)

2.6

(1.4-3.9)

12

4.1

(1.8-6.4)

4.8

(2.3-7.2)

7

2

(0.5-3.5)

1.4

(0.1-2.6)

<0.001

PDR

65

10.3

(7.9-12.6)

9.6

(7.3-11.9)

39

13.6

(9.6-17.6)

14.5

(10.4-18.6)

26

7.5

(4.7-10.3)

6.8

(4.1-9.5)

<0.001

  1. †Data presented in Crude and Standardized columns are percentages and confidence intervals 95%.
  2. * Age- standardized to the 2006 Tehran population census.
  3. ¶ P- Value for difference in prevalence and severity of retinopathy by gender, based on chi-square test.
  4. §CSME: Clinically significant macular edema, VTR: Vision threatening retinopathy